Physician

Abel Murillo, MD. DABPM. FIPP. MBA

According to 2025 Medicare claims, Abel Murillo, MD. DABPM. FIPP. MBA (NPI: 1063490852) practices pain management in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is LAUDAN PARTNERS INC (NPI: 1811050677; TIN: 201140206) and primary practice location at 33145-1233.

Murillo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 132 traditional Medicare patients, billed 5,292 HCPCS/CPT codes, and received $66,012 in Medicare payments. The top billing code was 62323 (Injection of substance into lower spine canal using imaging guidance). Part D data shows 805 prescription claims across 195 beneficiaries totaling $33,189 in drug costs, led by Fentanyl (Fentanyl). 2023 DME data shows 14 claims. Open Payments data shows 13 records totaling $388,895. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $208,426 to $66,012. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $377,529 to $33,189. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	400	2,494	$208,426
2016	347	2,068	$182,953
2017	351	1,603	$143,550
2018	320	1,320	$125,204
2019	319	1,222	$121,473
2020	243	1,170	$103,849
2021	244	1,229	$116,408
2022	236	1,474	$139,331
2023	228	1,089	$101,875
2024	132	5,292	$66,012

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	347	2,164	$377,529
2016	233	1,652	$359,694
2017	263	1,518	$127,714
2018	272	1,281	$92,271
2019	256	1,135	$66,267
2020	211	1,026	$49,448
2021	235	922	$38,700
2022	330	1,215	$47,463
2023	298	983	$44,728
2024	195	805	$33,189

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	27	27	$27,498
2016	55	55	$50,880
2017	40	41	$35,890
2018	28	28	$29,162
2019	30	30	$31,268
2020	36	36	$38,406
2021	27	27	$21,262
2022	18	18	$14,539
2023	14	14	$11,432
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
62323	Injection of substance into lower spine canal using imaging guidance	23	31	$204
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	30	30	$145
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	34	34	$141
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	62	172	$98
J1010	Injection, methylprednisolone acetate, 1 mg	38	4,652	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fentanyl	Fentanyl	48	1,440	$4,610
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	109	2,918	$3,079
Tramadol Hcl	Tramadol Hcl	119	3,207	$643
Acetaminophen-Codeine	Acetaminophen With Codeine	32	787	$566
Diclofenac Sodium	Diclofenac Sodium	37	989	$454

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$238	PAINTEQ LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	9	$388,657	Novavax Inc
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abel Murillo, MD. DABPM. FIPP. MBA?

Tedicare shows public-source Medicare data for Abel Murillo, MD. DABPM. FIPP. MBA (NPI 1063490852), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abel Murillo, MD. DABPM. FIPP. MBA have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abel Murillo, MD. DABPM. FIPP. MBA?

Abel Murillo, MD. DABPM. FIPP. MBA is linked to LAUDAN PARTNERS INC (billing NPI 1811050677) in the available physician profile data.

Does Abel Murillo, MD. DABPM. FIPP. MBA have Open Payments data?

Abel Murillo, MD. DABPM. FIPP. MBA has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.